Clinical Trial

Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA

Name: Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA — clinical trial record (NCT07418125)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GALIA

Recruiting

View on ClinicalTrials.gov →

Summary

CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.

Trial Details

NCT Number	NCT07418125
Lead Sponsor	Institute of Oncology Ljubljana
Conditions	Breast Cancer
Enrollment	130 participants
Start Date	2024-02-07
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-18